Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  4.80 0.34% 1,410.00 1,412.00 1,412.40 1,423.60 1,405.20 1,408.00 6,746,510 16:35:14
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 34,114.0 5,442.0 87.6 16.1 57,350

Gsk Share Discussion Threads

Showing 31651 to 31675 of 31675 messages
Chat Pages: 1267  1266  1265  1264  1263  1262  1261  1260  1259  1258  1257  1256  Older
DateSubjectAuthorDiscuss
26/1/2023
15:50
Thanks TM.
netcurtains
26/1/2023
15:41
Its almost a daily event, as soon as Wall Street opens .... ;0)
tradermichael
26/1/2023
15:32
A 10p price change on 1400-odd-p is hardly dramatic especially as the price is effectively level on the day so doesn't justify starting yet another rumour.
grahamburn
26/1/2023
15:23
Is there any breaking rumour that has caused this to go into the RED?
Its been GREEN all morning.
Any views as to why the change?

netcurtains
26/1/2023
14:24
Thank you BD.

I know NC probably cannot see this post (he may well bot have filtered me), but I, like you, I fail to see how quoting/summarising facts from a report can be classified as "agressive".

BBs are for reasoned debate and for exchanging opinions and ideas in a civilised, friendly manner.

NC saying the report is "sanitised" without providing evidence is verging on a rumour. That is potentially misleading.

grahamburn
26/1/2023
09:30
Haleon releases its fourth quarter and final year 2022 results on 2nd March. Credit Suisse predict organic sales growth of 3.7% and OTC growth of 5.0%.

On an earnings discount to European rivals, 'outperform' is the investment rating with a share price target of 376p.

tradermichael
26/1/2023
09:28
Share price recovering a little
alibizzle
26/1/2023
08:02
bothdavis: I did not block him for that. I dont want to discuss it further. Thank you. Its not called debate its called being overly aggressive and self righteous. He had to go. Share investing can get overly emotional and I dont need this agro thrown on top. I personally did not have 4th jab. I'm reasonably glad I did not. Many other people see it differently. I know that. Thank you for not debating this. Ad nauseum
netcurtains
25/1/2023
22:25
Why block grahamburn for stating what is in the report?

The review of more than 8,000 reported cases from 46 studies by researchers in Canada confirms previous reports that myocarditis is rare, but cases are highest among young males shortly after a second dose, and are probably higher after Moderna’s mRNA vaccine than after Pfizer’s vaccine.

It also shows that, while cases are predominantly mild, the risk of myocarditis or pericarditis might be lower when the second dose is given more than 30 days after the first dose.

However, the researchers warn that, in general, the evidence is of low certainty and say these findings must be considered alongside the overall benefits of vaccination.

So~: 'confirms previous reports that myocarditis is rare', the evidence is of low certainty and.......findings must be considered alongside the overall benefits of vaccination'

It is called 'debate', and I'm afraid it merely backs up the facts that vaccination is the best thing to have done for the population as a whole.

bothdavis
25/1/2023
18:49
grahamburn blocked. (Filtered)
netcurtains
25/1/2023
18:25
Try reading the first line of that report before scaremongering, as well as the second and third lines.

To assist, here they are:
Number of cases low and predominantly mild
Young males at highest risk shortly after second dose, suggesting longer dosing intervals might be beneficial
Findings must be considered alongside overall benefits of vaccination

Then read and absorb the detail following.

Finally, perhaps re-post (or publicly edit) 31452 without "more and more".

Facts are always better than rumours.

grahamburn
25/1/2023
15:14
bothdavis: Its not rumour:

Https://www.bmj.com/company/newsroom/new-study-updates-evidence-on-rare-heart-condition-after-covid-vaccination/

This is the sanitised version - as news comes out it probably will get worse.
I did not have 4th jab.

Reasonably happy that I did not (I have had covid - mild case)

netcurtains
25/1/2023
14:57
Haven't heard anything myself with regards to COVID injections, had my four. Whats the rumours?
bothdavis
25/1/2023
13:19
I hear more and more people complaining about phizer Covid-19 injections- great Gsk not involved
netcurtains
25/1/2023
12:58
Here's hoping for a favourable court outcome , and that the trial won't last long and a result issued quickly . Also for haleon to be taken over.
alibizzle
25/1/2023
11:17
This is holding the share price back:

Among the state court cases naming GSK, a trial in California is currently scheduled to begin 13 February 2023 and a trial is currently scheduled to begin in Madison County, Illinois in February 2023.

Given the early stage of this litigation, it is not possible to quantify or reliably estimate what liability (if any) GSK or any other parties may have in this litigation.

A favourable result will see the share price absolutely rocket .... ;o)

tradermichael
25/1/2023
09:46
Is it rising towards next WEDNESDAYS final results?
I guess I'll have to wait and see.

netcurtains
24/1/2023
21:54
I'm not GSK's biggest advocate but I very much doubt we'll see £11!
rikky72
24/1/2023
20:06
This will not impress next week. The books are being printed, the leaks have happened.This has £11 written all over it.It will come good, but not til Q4
rongetsrich
24/1/2023
19:39
Thanks for the correction Supermarky!
Well spotted.

netcurtains
24/1/2023
18:12
We will announce our full year and fourth quarter 2022 results on Wednesday 1 February 2023.
supermarky
24/1/2023
17:14
I'm looking from the sidelines.
ADVFN have the dividend at 5.77% at this price, but the chart doesn't look too good.
1350 good entry point if it gets that low?

gswredland
24/1/2023
16:59
Net
I'm still out of GSK (waiting for a good point to re-enter). Just wanted to say how much I enjoy reading your informative posts.

jonjoneil
24/1/2023
16:05
TraderMichael: Is it possible that the City knows that TUESDAYS results will be good and this is the crouching down before the rise?
netcurtains
24/1/2023
15:43
5 years now at the helm for Dame Emma Walmsley. The job is to creat value for shareholders. It is not working the evidence is the share price, the dividend cut and the loss of confidence by the market. How does a failing CEO get removed? Note: by comparison to AZ Pascal Spirit had turned AZ around well before 5 years.
fidepax1
Chat Pages: 1267  1266  1265  1264  1263  1262  1261  1260  1259  1258  1257  1256  Older
Your Recent History
LSE
GSK
Gsk
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230127 22:17:11